Pathological complete response to FLOT chemotherapy with/without durvalumab in resectable gastric and gastroesophageal junction cancer:subgroup analysis by region from the phase 3, randomized, double-blind MATTERHORN study Meeting Abstract
| Authors: | Janjigian, Y. Y.; Al-Batran, S. E.; Wainberg, Z. A.; Van Cutsem, E.; Molena, D.; Muro, K.; Hyung, W. J.; Wyrwicz, L.; Oh, D. Y.; Omori, T.; Moehler, M.; Garrido, M.; Oliveira, S. C. S.; Liberman, M.; Oliden, V. C.; Bilici, M.; Kurland, J.; Xynos, I.; Mann, H.; Tabernero, J. |
| Abstract Title: | Pathological complete response to FLOT chemotherapy with/without durvalumab in resectable gastric and gastroesophageal junction cancer:subgroup analysis by region from the phase 3, randomized, double-blind MATTERHORN study |
| Meeting Title: | Society of Surgical Oncology (SSO 2024) Annual Meeting |
| Journal Title: | Annals of Surgical Oncology |
| Volume: | 31 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Mar 20-23 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 1068-9265 |
| Publisher: | Springer |
| Date Published: | 2024-03-01 |
| Start Page: | S44 |
| End Page: | S45 |
| Language: | English |
| ACCESSION: | WOS:001185577500091 |
| PROVIDER: | wos |
| DOI: | 10.1245/s10434-024-15179-y |
| Notes: | Meeting Abstract: 90 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
